Erika Geimonen has more than 30 years of experience in business development and research. She is proficient in management, operations, business development and strategic planning coupled with extensive technical knowledge. In addition, Erika mentors and serves on the boards of startup companies and assists them with their corporate, business and financing activities. Erika holds her M.S. in biology and Ph.D. in biology and biochemistry from Moscow State University in Russia and an M.S. in management and policy from the College of Business at the State University of New York in Stony Brook, USA. | Laura E. Randa serves as Chief Executive Officer and Chair of Toivoa and serves as Chairman of Toivoa Coaching. Toivoa has a singular mission to improve the lives of people with chronic illness or disabilities struggling with mental health, providing accessible, personalized clinically validated digital therapeutics with board-certified - National Board For Health and Wellness Coaches.
Ms. Randa is a seasoned healthcare and life sciences healthcare executive with three decades of experience building high-performing teams and successfully leading companies. Throughout her career in senior executive roles, she has been in the C-Suite, provided corporate leadership, executed successful turnarounds, and held responsibility for multi-billion-dollar P&L’s. She has successfully lead teams of up to 1000 people through commercial launches to maximize returns, with a focus on driving a fast trajectory to peak sales. Her diverse experience includes large biopharmaceuticals, biotech, managed care, government, specialty and retail pharmacy, hospital systems, public policy, healthcare services, and consulting.
Ms. Randa is a visionary executive who knows how to raise capital communicate the value of the organization, help mentor the senior executive team leadership to deliver market innovation that drives revenue growth, and profitability, and strengthens market positions. Ms. Randa brings her commercial experience with 33 new brand drug launches in driving pre-launch activities early in the R&D cycle, including early engagement with customers to co-develop the product value proposition (aligning R&D, Medical, and Commercial). Her experience in successful commercialization includes leading the commercial strategy at Regeneron for Dupixent, which is one of the top 3 most successfully commercialized products slated to hit the $20Bn mark in annual sales later this decade.
Ms. Randa serves as a Member of the Board of Directors for the American Association of People with Disabilities. She was a founding member of the American Association of People with Disabilities’ new Disability Advisory Roundtable. | |
Print Page